Testosterone, like many anabolic steroids, was classified as a controlled substance in 1991. Testosterone is administered parenterally in normal and delayed-release (depot) forms. In September 1995, the FDA approved testosterone transdermal patches (Androderm), and many transdermal forms and brands are now available including implants, gels, and topical solutions. A testosterone buccal system, Striant, was FDA-approved in July 2003; Striant is a mucoadhesive product that adheres to the buccal mucosa and provides a controlled and sustained release of testosterone. In May 2014, the FDA approved an intranasal gel formulation of testosterone (Natesto). A transdermal patch (Intrinsa) for hormone replacement in women is under investigation; the daily dosages used in women are much lower than for products used in males. The FDA refused approval for Intrinsa in 2004 stating that more data regarding safety, especially in relation to cardiovascular and breast health, were required.
Advance Therapy provides hormone replacement therapy information, services and products including Testosterone, HCG and HGH. Medical Consultation, Age Management Physician Specialist, Testosterone Doctor, HGH Therapy Doctor, Anti-Aging and US Physician specialist referal is availble for adult hormone deficiency related symptoms. We also provide diet, exercise and fitness, lifestyle change, healthy aging, IV therapy, detoxification and nutritional program information. No information on this website is intended to cure any medical or health condition and is solely for informational and educational purpose.
Copyright Advance Therapy, LLC All Rights Reserved 2003-2017